These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14630193)

  • 1. Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligands.
    Horner AA; Raz E
    Curr Opin Immunol; 2003 Dec; 15(6):614-9. PubMed ID: 14630193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors as adjuvant receptors.
    Kaisho T; Akira S
    Biochim Biophys Acta; 2002 Feb; 1589(1):1-13. PubMed ID: 11909637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From plankton to pathogen recognition.
    Modlin RL; Cheng G
    Nat Med; 2004 Nov; 10(11):1173-4. PubMed ID: 15516915
    [No Abstract]   [Full Text] [Related]  

  • 4. Toll-like receptor ligands and atopy: a coin with at least two sides.
    Horner AA
    J Allergy Clin Immunol; 2006 May; 117(5):1133-40. PubMed ID: 16675343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor ligands directly promote activated CD4+ T cell survival.
    Gelman AE; Zhang J; Choi Y; Turka LA
    J Immunol; 2004 May; 172(10):6065-73. PubMed ID: 15128790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T; Barton GM; Flavell RA; Medzhitov R
    Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor signaling.
    Akira S
    J Biol Chem; 2003 Oct; 278(40):38105-8. PubMed ID: 12893815
    [No Abstract]   [Full Text] [Related]  

  • 8. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
    Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
    J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial cells pay a Toll for protection.
    Strober W
    Nat Med; 2004 Sep; 10(9):898-900. PubMed ID: 15340409
    [No Abstract]   [Full Text] [Related]  

  • 11. Myeloid differentiation factor 88-dependent and -independent pathways in toll-like receptor signaling.
    Akira S; Hoshino K
    J Infect Dis; 2003 Jun; 187 Suppl 2():S356-63. PubMed ID: 12792852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling.
    Gohda J; Matsumura T; Inoue J
    J Immunol; 2004 Sep; 173(5):2913-7. PubMed ID: 15322147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.
    Häcker H; Vabulas RM; Takeuchi O; Hoshino K; Akira S; Wagner H
    J Exp Med; 2000 Aug; 192(4):595-600. PubMed ID: 10952730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.
    Ruckdeschel K; Pfaffinger G; Haase R; Sing A; Weighardt H; Häcker G; Holzmann B; Heesemann J
    J Immunol; 2004 Sep; 173(5):3320-8. PubMed ID: 15322195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wanted: a molecular basis for specificity in toll-like receptor signal transduction.
    O'Neill LA
    Mol Cell; 2002 Nov; 10(5):969-71. PubMed ID: 12453406
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunology: a block at the toll gate.
    Mak TW; Yeh WC
    Nature; 2002 Aug; 418(6900):835-6. PubMed ID: 12192398
    [No Abstract]   [Full Text] [Related]  

  • 17. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling.
    Schmitz F; Mages J; Heit A; Lang R; Wagner H
    Eur J Immunol; 2004 Oct; 34(10):2863-73. PubMed ID: 15368303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor ligands: hygiene, atopy and therapeutic implications.
    Horner AA; Redecke V; Raz E
    Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):555-61. PubMed ID: 15640699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.
    Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G
    J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.
    Datta SK; Redecke V; Prilliman KR; Takabayashi K; Corr M; Tallant T; DiDonato J; Dziarski R; Akira S; Schoenberger SP; Raz E
    J Immunol; 2003 Apr; 170(8):4102-10. PubMed ID: 12682240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.